Titanium jaw implant could replace bone grafts in cancer patients
NCT ID NCT00213837
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 2 trial tested a new porous titanium implant to rebuild the front part of the jaw after it is removed during cancer surgery. The implant is designed to avoid the need for bone grafts taken from elsewhere in the body, which can cause additional pain and complications. Seven adults participated, and the study looked at how well the implant worked and any complications that occurred.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- porous titanium mandibular prosthesis
- What this could lead to
- If successful, this implant could offer a simpler, safer way to rebuild the jaw after cancer surgery, reducing the need for complex bone grafts.
- What could go wrong
- This is a very small early-phase trial with only 7 participants, so results may not apply widely. The implant may fail to integrate or cause complications like infection or rejection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OTORHINOLARYNGOLOGIC DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service d'Oto-Rhino-Laryngologie et de Chirurgie Cervico-Faciale, Hôpital de Hautepierre
Strasbourg, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.